Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented, it ...

SCIENTISTS have said that human-induced climate change increased the severity of the 2021-2022 drought in the Horn of Africa.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV by keeping more patients ...

We found that programs that expand and promote adherence to treatment are powerful. Prevention efforts among key populations are vital. Cases must be identified through HIV testing programs.

Every prevented HIV infection represents not only a human life improved but also decades of treatment costs avoided. Analysis suggests that delayed implementation of breakthrough prevention ...

UNC is also home to one of the largest HIV cure initiatives in the world. The new grant provides funding through 2021 for five clinical research sites that make up the UNC Global CTU: Chapel Hill, ...

Despite an emergency humanitarian waiver ensuring temporary access to HIV treatment, many patients are uncertain about the future, fearing potential disruptions to their medication and essential ...